Kintor Pharmaceutical Limited (HKG:9939)
Hong Kong
· Delayed Price · Currency is HKD 4.050
+0.970 (31.49%)
At close: Mar 10, 2026
Kintor Pharmaceutical Market Cap
Kintor Pharmaceutical has a market cap or net worth of 1.52 billion as of March 10, 2026. Its market cap has increased by 265.71% in one year.
Market Cap
1.52B
Enterprise Value
1.56B
Revenue
12.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.05
Market Cap Chart
Since May 22, 2020, Kintor Pharmaceutical's market cap has decreased from 7.94B to 1.52B, a decrease of -80.86%. That is a compound annual growth rate of -24.80%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HighTide Therapeutics | 1.51B |
| Immunotech Biopharm | 1.46B |
| Mabpharm | 1.69B |
| Cutia Therapeutics | 1.71B |
| Beijing Biostar Pharmaceuticals | 1.33B |
| CANbridge Pharmaceuticals | 1.27B |
| Zhaoke Ophthalmology | 1.86B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.93B |